Acromegaly: A single centre's experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator

Journal of Clinical Neuroscience

Volumn 20, Issue 11, 2013, Pages 1506-1513

  Wilson, P J ^a   De Loyde, K J ^a   Williams, J R ^a   Smee, R I ^a  

^a The Prince of Wales Cancer Centre   (Australia)

Author keywords

Acromegaly; Endocrine replacement therapy; Pituitary tumours; Radiation therapy; Surgery; Tumour control

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CONTROLLED STUDY; CONVENTIONAL RADIOTHERAPY; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; GAMMA KNIFE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING ADENOMA; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RADIOTHERAPY; STEREOTACTIC RADIOSURGERY; TUMOR VOLUME;

ACROMEGALY; ENDOCRINE REPLACEMENT THERAPY; PITUITARY TUMOURS; RADIATION THERAPY; SURGERY; TUMOUR CONTROL;

ADENOMA; ADULT; AGED; FEMALE; GROWTH HORMONE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84886086377     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.11.026     Document Type: Article

References (34)

1. A. Mammis, J.A. Eloy, and J.K. Liu Early descriptions of acromegaly and gigantism and their historical evolution as clinical entities Neurosurg Focus 29 2010 E1
2. J. Ayuk, and M.C. Sheppard Does acromegaly enhance mortality? Rev Endocr Metab Disord 9 2008 33 39
3. A. Colao, R.S. Auriemma, and R. Pivonello Medical consequences of acromegaly: what are the effects of biochemical control? Rev Endocr Metab Disord 9 2008 21 31
4. A.G. Renehan, J. O'Connell, and D. O'Halloran Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications Horm Metab Res 35 2003 712 725
5. A. Giustina, M.D. Bronstein, and F.F. Casanueva Current management practices for acromegaly: an international survey Pituitary 14 2011 125 133
6. M. Luque-Ramírez, A. Carreño, and C. Alvarez Escolá The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies Endocrinol Nutr 58 2011 478 486
7. P. Nomikos, M. Buchfelder, and R. Fahlbusch The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure' Eur J Endocrinol 152 2005 379 387
8. M.D. Bronstein Optimizing acromegaly treatment Front Horm Res 38 2010 174 183
9. P.U. Freda Somatostatin analogs in acromegaly J Clin Endocrinol Metab 87 2002 3013 3018
10. N.R. Biermasz, F. Roelfsema, and A.M. Pereira Cost-effectiveness of lanreotide autogel in treatment algorithms of acromegaly Expert Rev PharmacoEcon Outcomes Res 9 2009 223 234
11. G. Minniti, C. Scaringi, and R.M. Enrici Radiation techniques for acromegaly Radiat Oncol 6 2011 167
12. N. Friedrich, D. Alte, and H. Völzke Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP) Growth Horm IGF Res 18 2008 228 237
13. L.A. Del Porto, S.V. Liubinas, and A.H. Kaye Treatment of persistent and recurrent acromegaly J Clin Neurosci 18 2011 181 190
14. G. Minniti, C. Scaringi, and D. Amelio Stereotactic irradiation of GH-secreting pituitary adenomas Int J Endocrinol 2012 2012 482861
15. J. Voges, M. Kocher, and M. Runge Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study Cancer 107 2006 1355 1364
16. F.M. Swords, C.A. Allan, and P.N. Plowman Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas J Clin Endocrinol Metab 88 2003 5334 5340
17. J.H. Petit, B.M.K. Biller, and J.J. Coen Proton stereotactic radiosurgery in management of persistent acromegaly Endocr Pract 13 2007 726 734
18. B.K. Roberts, D.L. Ouyang, and S.P. Lad Efficacy and safety of CyberKnife radiosurgery for acromegaly Pituitary 10 2007 19 25
19. M.C. Sheppard GH and mortality in acromegaly J Endocrinol Invest 28 2005 75 77
20. A. Giustina, A. Barkan, and F.F. Casanueva Criteria for cure of acromegaly: a consensus statement J Clin Endocrinol Metab 85 2000 526 529
21. I. Yang, W. Kim, and A. De Salles A systematic analysis of disease control in acromegaly treated with radiosurgery Neurosurg Focus 29 2010 E13
22. J.D. Rolston, and L.S. Blevins Jr. Gamma knife radiosurgery for acromegaly Int J Endocrinol 2012 2012 821579
23. X. Liu, H. Kano, and D. Kondziolka Gamma knife radiosurgery for clinically persistent acromegaly J Neurooncol 109 2012 71 79
24. F.M. Erdur, T. Kilic, and S. Peker Gammaknife radiosurgery in patients with acromegaly J Clin Neurosci 18 2011 1616 1620
25. C.B. Cho, H.K. Park, and W.I. Joo Stereotactic radiosurgery with the CyberKnife for pituitary adenomas J Korean Neurosurg Soc 45 2009 157 163
26. K. Kajiwara, K. Saito, and K. Yoshikawa Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas Minim Invasive Neurosurg 48 2005 91 96
27. B.E. Pollock, J.T. Jacob, and P.D. Brown Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission J Neurosurg 106 2007 833 838
28. F. Castinetti, J. Régis, and H. Dufour Role of stereotactic radiosurgery in the management of pituitary adenomas Nat Rev Endocrinol 6 2010 214 223
29. J. Jagannathan, J.P. Sheehan, and N. Pouratian Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery Neurosurgery 62 2008 1262 1269 [discussion 1269-1270]
30. X. Muracciole, and J. Régis Radiosurgery and carcinogenesis risk Prog Neurol Surg 21 2008 207 213
31. K. Schindler, E.R. Christ, and T. Mindermann Transient MR changes and symptomatic epilepsy following gamma knife treatment of a residual GH-secreting pituitary adenoma in the cavernous sinus Acta Neurochir (Wien) 148 2006 903 908 [discussion 908]
32. A.M. Landolt, D. Haller, and N. Lomax Octreotide may act as a radioprotective agent in acromegaly J Clin Endocrinol Metab 85 2000 1287 1289
33. M. Rezácová, J. Cáp, and D. Vokurková Effect of somatostatin on repair of ionizing radiation-induced DNA damage in pituitary adenoma cells GH3 Physiol Res 57 2008 225 235
34. S. Ning, S.J. Knox, and G.R. Harsh Lanreotide promotes apoptosis and is not radioprotective in GH3 cells Endocr Relat Cancer 16 2009 1045 1055